sorafenib,tremelimumab,durvalumab
astrazeneca,pfizer
[]
the stride regimen was effective in treating liver cancer, and the side effects were tolerable, according to research presented at #asco23. 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.